High-dose rifampicin and clarithromycin for 4 weeks versus standard-dose rifampicin and clarithromycin for 8 weeks to treat Buruli ulcer: An open-label, individually randomized, controlled trial in Ghana
Abstract
Background
The current 8-week regimen of rifampicin and clarithromycin for Buruli ulcer (BU) is suboptimal. High-dose rifampicin could shorten treatment and improve outcomes. We evaluated …
This is a preview of the original article. Source: Plos.org · Abigail Agbanyo, Yaw Ampem Amoako, Charles Opondo, Michael Ntiamoah Oppong, Adwoa Asante-Poku, Jacob Novignon, Joseph Tuffour, Ishaque Saim Mintah, Ruth Dede Tuwor, Dzifa Kofi Ahiatrogah, Richard Adjei Akuffo, Miriam Gborglah, Iris Mosweu, Catherine Pitt, Elizabeth Allen, Stephen L. Walker, Dorothy Yeboah-Manu, Michael Marks, Richard Odame Phillips, SHARP Collaboration
